Contrast Injection Lines Market to Reach Valuation of USD 5,459.4 Billion by 2028 - Increasing Prevalence of Cancer and CVD & Rising Grants by Government organizations are Key factors that are expected to Generate Revenue from the Contrast Injection Lines Market

In terms of revenue, the Global Contrast Injection Lines Market is expected to reach USD 5,459.4 Billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 4.40% from 2022 to 2028.

Recently, there have been significant developments in Contrast Injection Lines technology. Lower costs, automated data collection for dosing patients, and others show enormous potential for market development. Contrast dose recording software also offers new possibilities for radiology departments looking to streamline and document their contrast media usage. Factors such as the increasing prevalence of cancer patients and various grants provided by the government sector are driving the market demand.

Key Findings:

• The Consumables sub-segment of the Product Type segment is anticipated to dominate the Contrast Injection Lines Market. The rise in this segment is attributed to the growing demand for consumables offering high safety and regulations during diagnostic procedures.

• The Radiology sub-segment of the End-Use Application segment dominates by holding the largest market share in 2021 for the Contrast Injection Lines Market. The growth is attributed to the increasing prevalence of cancer patients across the globe.

• Asia Pacific is the largest regional segment. This surge is attributed to the rising demand for contrast injection lines in developing economies such as India, China, and Indonesia. The rising technological advancements and increasing government support to promote this system are major factors driving the market growth.

According to World Health Organization (WHO), 21.6 million people are diagnosed with cancer. This number is expected to increase further up to 50% in 2023. Similarly, CVD and strokes are causing deaths worldwide at a higher rate. In 2021, 19.2 million people died of CVDs, which represents 35% of the world population. Contract media injection lines are used for diagnosing. Thus, the increase in the number of cancer and CVD cases will stimulate the demand for improved healthcare facilities and advanced diagnostic imaging procedures, which, in turn, will drive the market for contrast media injectors.

Asia Pacific is expected to dominate the global Contrast Injection Lines Market in 2021 and is likely to continue the same trend during the forecast period. An increase in critical players and high investment made countries such as China & India is expected to generate demand for this market shortly in this region.